期刊文献+

浅谈医院药品风险管理 被引量:18

Risk Management of Hospital Medicine
下载PDF
导出
摘要 目的探讨医院药品使用风险的因素和对策,以引起广大医务人员对药品使用过程中风险的重视,保障公众用药安全。方法从药品风险管理基本概念入手,结合医院药品使用各个环节容易出现的风险问题,有针对性地进行阐述和分析。结果医院作为药品使用的主要场所,围绕实现"患者用药收益最大化、风险最小化"的核心目标,加强药品风险管理,已经成为医院管理者思考和面临的课题。结论医师、药师和护士在药品风险管理工作中既有分工又有合作,不可或缺。医院要有计划、分步骤地建立和健全药品风险管理系统,逐渐提高技术能力、评价能力、风险预警能力、风险管理操作能力,从而推动医院药品风险管理工作的有效开展。 Objective To investigate the risk factors of hospital drug use and measures to attract large numbers of medical personnel on the attention of the risks during the drug use, to ensure safe use of drugs. Methods From the basic concept of risk management drugs, risks that can easily arise in all aspects of hospital drug use were described and analyzed. Results The hospital, as the main place of drug use, around carrying out the core objective of " patient medication maximize return, minimize risk," strengthening risk management has become a hospital pharmaceutical managers to think and face the issue. Conclusion Physicians, pharmacists and nurses work in drug risk management for division and co-operate in both indispensable. Hospitals must have plans, step by step to establish and improve risk management system of drugs, and gradually improve the technical capacity, capability assessment, risk early warning capability and operational capabilities of risk management, so as to promote the effective work of hospital drug risk management.
作者 赵阿娜 刘磊
出处 《中国药事》 CAS 2010年第5期419-422,425,共5页 Chinese Pharmaceutical Affairs
关键词 医院 药品 风险管理 hospital drugs risk management
  • 相关文献

参考文献15

  • 1陈易新.如何通过上市后药品安全性监测实现药品风险管理[J].中国药师,2007,10(4):375-377. 被引量:33
  • 2卫生部.处方管理办法[Z].卫医发[2009] 53号,2009.
  • 3卫生部,国家中医药管理局.医疗机构药事管理暂行规定[Z].卫医发[2002] 24号,2002.
  • 4麻醉药品和精神药品管理条例[S].国务院令第442号:2005
  • 5卫生部办公厅.关于加强医疗机构含兴奋剂药品使用管理的通知[Z].卫办医发[2008] 61号,2008.
  • 6中国执业药师协会.中国执业药师职业道德准则[Z].2007.
  • 7执业医师法[S].中华人民共和国主席令第5号,1999.
  • 8卫生部.护士管理办法[Z].卫医发[1993] 31号,1993.
  • 9药品管理法[S].中华人民共和国主席令第45号,2001.
  • 10药品不良反应报告和监测管理办法[S].国家食品药品监督管理局令第73号,2004.

二级参考文献11

  • 1蒯丽萍,张钧.药物经济学的成本-效果分析[J].药学实践杂志,2005,23(4):251-255. 被引量:68
  • 2[1]Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events[J]. JAMA. 1995,274(1):35.
  • 3[2]Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit[J]. JAMA. 1999 ,282(3):267.
  • 4[3]Bates DW, Leape LL, Culen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors[J]. JAMA, 1998,280(15): 1311.
  • 5[4]Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions[J]. Clin Phar Ther,1981,30(2):239~45.
  • 6[5]Report of the Quality Interagency Coordination Task Force (QUIC). Doing what counts for patient safety: Federal actions to reduce medical errors and their impact[J]. 2002; February: 37.
  • 7[6]Classen DC, Pestotnik SL, Evars RS, et al. Adverse drug events in hospitalized patients[J]. JAMA, 1997, 277(17):301.
  • 8[7]Miyagawa CI, Rivera JO. Effect of pharmacist intervention on drug therapy at a surgical intensive care unit[J]. Am J Hosp Pharm, 1986,43(5):3008.
  • 9Michael F,Bernie J,Greg L,et al.Method for the economic evaluation of health care programmes second edition[M].Oxford University Press New York,1997:139~ 193.
  • 10杨樟卫,陈盛新,胡晋红.健康相关生活质量的评价和药物经济学[J].药学实践杂志,1998,16(1):5-9. 被引量:30

共引文献117

同被引文献120

引证文献18

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部